John Chirgwin

  • 25138 Citations
  • 47 h-Index
1972 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where John Chirgwin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications

Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo

Miyagawa, K., Ohata, Y., Delgado-Calle, J., Teramachi, J., Zhou, H., Dempster, D. D., Subler, M. A., Windle, J. J., Chirgwin, J. M., David Roodman, G. & Kurihara, N., Mar 26 2020, In : JCI Insight. 5, 6, e133113.

Research output: Contribution to journalArticle

Open Access
  • Small molecules inhibit ex vivo tumor growth in bone

    Zhou, D., Bum-Erdene, K., Xu, D., Liu, D., Tompkins, D., Sulaiman, R. S., Corson, T. W., Chirgwin, J. M. & Meroueh, S. O., Dec 15 2018, In : Bioorganic and Medicinal Chemistry. 26, 23-24, p. 6128-6134 7 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    The role of Semaphorin 4D in bone remodeling and cancer metastasis

    Lontos, K., Adamik, J., Tsagianni, A., Galson, D. L., Chirgwin, J. M. & Suvannasankha, A., Jun 19 2018, In : Frontiers in Endocrinology. 9, JUL, 322.

    Research output: Contribution to journalReview article

  • 6 Scopus citations

    Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis

    Juárez, P., Fournier, P. G. J., Mohammad, K. S., McKenna, R. C., Davis, H. W., Peng, X. H., Niewolna, M., Mauviel, A., Chirgwin, J. M. & Guise, T. A., Oct 17 2017, In : Oncotarget. 8, 49, p. 86447-86462 16 p.

    Research output: Contribution to journalArticle

  • 9 Scopus citations
  • 75 Scopus citations